Filing Details

Accession Number:
0000899243-22-016320
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-03 16:28:33
Reporting Period:
2022-04-29
Accepted Time:
2022-05-03 16:28:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1847529 Joy Liu C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-04-29 17 $273.37 14,437 No 4 S Direct
Common Stock Disposition 2022-04-29 41 $274.75 14,396 No 4 S Direct
Common Stock Disposition 2022-04-29 30 $275.62 14,366 No 4 S Direct
Common Stock Disposition 2022-04-29 22 $276.72 14,344 No 4 S Direct
Common Stock Disposition 2022-04-29 10 $278.04 14,334 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
  2. Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87).
  4. Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14).
  5. Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19).
  6. Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06).